Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel
Open Access
- 8 December 2008
- journal article
- Vol. 14, 2263-2271
Abstract
Single nucleotide polymorphisms (SNPs) in the tightly linked LOC387715/ARMS2 and HTRA1 genes have been associated with age-related macular degeneration (AMD). We tested whether these SNPs are associated with AMD in Israeli populations, if they underlie variable phenotype and response to therapy in neovascular AMD (NVAMD), and if HTRA1 expression in vivo is associated with its promoter variant. Genotyping for the rs10490924 SNP in LOC387715/ARMS2 and the rs11200638 SNP in HTRA1 was performed on 255 NVAMD patients and 119 unaffected controls from Ashkenazi and Sephardic Jewish, and from Arab origins which are the main ethnic groups composing the Israeli population. Genotyping was correlated with phenotype and response to therapy among 143 patients who underwent photodynamic therapy (PDT). HTRA1 mRNA levels in white blood cells (WBCs), measured by quantitative PCR, were correlated with genotype in 27 participants. Both SNPs were in almost complete linkage disequilibrium (D'=0.96–1). Homozygotes for the T allele of rs10490924 had an odds ratio (OR) of 8.6, with a 95% confidence interval (CI) of 3.5–20.8, and homozygotes for the A allele of rs11200638 had an OR of 10.7, with a 95% CI of 3.2–35.7, for having AMD (p<0.00001). There was no association among these SNPs and phenotype or response to PDT. HTRA1 mRNA levels in WBCs were not associated with rs11200638 genotypes. The rs10490924 SNP in LOC387715/ARMS2 and the rs11200638 SNP in HTRA1 are strongly associated with NVAMD in this Israeli population. These variants do not have a major contribution to the variable phenotype and response to PDT which characterize NVAMD.Keywords
This publication has 40 references indexed in Scilit:
- Association of Complement Factor H and LOC387715 Genotypes with Response of Exudative Age-Related Macular Degeneration to Intravitreal BevacizumabOphthalmology, 2007
- HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese populationVision Research, 2007
- PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.2007
- LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy and Age-related Macular Degeneration in a Japanese PopulationAmerican Journal of Ophthalmology, 2007
- A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degenerationProceedings of the National Academy of Sciences of the United States of America, 2007
- Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese populationJournal of Human Genetics, 2007
- Association of CFH Y402H and LOC387715 A69S With Progression of Age-Related Macular DegenerationJAMA, 2007
- HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration2007
- A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular DegenerationScience, 2006
- HTRA1 Promoter Polymorphism in Wet Age-Related Macular DegenerationScience, 2006